Rhytab 7.5 mg | Ivabradine Hydrochloride
₨ 290.00 (-7%)
Rhytab 7.5 mg:
Rhytab 7.5 mg tablet facilitates the individuals with chronic heart failure to lessen the probability of institutionalization for deteriorating heart failure.
Heart failure in children 6 months and older, with symptoms caused by an enlarged heart, may also be treated with this medication.
Each film-coated tablet contains Ivabredine Hydrochloride MS 7.5 Mg and 5 Mg.
Brand: Sami Pharmaceuticals
Symptomatic Treatment of chronic stable angina pectoris:
indicated for the symptomatic treatment of chronic stable angina pectoris coronary artery disease in adults with normal sinus rhythm and heart rate > 70 BPM. Then
Ivabradine is indicated :
Adults who are unable to tolerate or with a contraindication to the use of beta-blocker.
Or in combination with beta-blockers in patients inadequately controlled with an optimal beta-blocker dose.
Treatment of chronic heart failure: ivabradine is indicated in the chronic heart failure NYHA LL to IV class with systolic dysfunction, inpatient in sinus rhythm, and whose heart rate is > 75 BPM, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.
How to get it: Purchase this product online by logging onto http://fareedpharma.com or calling +923005080963.
As physician advises and to be sold on the prescription of RMP only.
Special Warning and precaution for uses:
Lack of benefit on clinical outcomes in patients with symptomatic chronic stable angina pectoris:
indicated only for symptomatic treatments of chronic stable angina pectoris because ivabradine has no benefit on cardiovascular outcomes (e.g mi infarction or cardiovascular death)